文献速递血液净化与透析肾血管病与高血压

透析液钠浓度调整而非超滤量或透析时间影响血透患者组织钠沉积

Modification of Dialysate Na+ Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na+ Deposition in Patients on Hemodialysis.
PubMed 文献 · Kidney Int Rep · 2024-02-09

本研究通过横断面分析(n=75)、队列研究和交叉干预研究(各n=10),采用23Na磁共振成像评估超滤量、透析时间延长及透析液钠浓度对血透患者组织钠含量的影响。结果显示仅透析液钠浓度调整可重复性影响皮肤钠含量,而超滤量和透析时间无显著影响。

要点

  • 透析液钠浓度<138 mmol/l的患者皮肤钠含量低于≥138 mmol/l者。
  • 个体内透析液钠浓度从138降至135 mmol/l可降低皮肤钠含量。
  • 超滤量和透析时间延长未显著改变组织钠含量。

核心结论

  • 仅调整透析液钠浓度对组织钠含量有可重复的影响。

研究设计与样本

  • 横断面分析纳入75例血透患者,队列研究和交叉干预研究各纳入10例患者,使用23Na磁共振成像评估组织钠含量。

主要发现

  • 透析液钠浓度<138 mmol/l的17例患者皮肤钠含量为20.7 ± 7.3 a.u.,低于透析液钠浓度≥138 mmol/l的58例患者的26.0 ± 8.8 a.u.(P < 0.05)。
  • 个体内透析液钠浓度从138降至142再降至135 mmol/l,皮肤钠含量相应为24.3 ± 7.6、26.3 ± 8.0、20.8 ± 5.6 a.u.(每次比较P < 0.05),肌肉钠无显著变化。
  • 超滤量和透析治疗时间延长均未显著影响组织钠含量。

临床怎么用

  • 调整透析液钠浓度可能作为减少血透患者组织钠沉积的策略。
  • 23Na磁共振成像可用于监测透析液钠浓度调整的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Tissue Na+ overload is present in patients receiving hemodialysis (HD) and is associated with cardiovascular mortality. Strategies to actively modify tissue Na+ amount in these patients by adjusting the HD regimen have not been evaluated. METHODS: In several substudies, including cross-sectional analyses (n = 75 patients on HD), a cohort study and a cross-over interventional study (n = 10 patients each), we assessed the impact of ultrafiltration (UF) volume, prolongation of dialysis treatment time, and modification of dialysate Na+ concentration on tissue Na+ content using 23Na magnetic resonance imaging (23Na-MRI). RESULTS: In the cross-sectional analysis of our patients on HD, differences in dialysate sodium concentration ([Na+]) were associated with changes in tissue Na+ content, whereas neither UF volume nor HD treatment time affected tissue Na+ amount. Skin Na+ content was lower in 17 patients on HD, with dialysate [Na+] of <138 mmol/l compared to 58 patients dialyzing at ≥138 mmol/l (20.7 ± 7.3 vs. 26.0 ± 8.8 arbitrary units [a.u.], P < 0.05). In the cohort study, intraindividual prolongation of HD treatment time was not associated with a reduction in tissue Na+ content. Corresponding to the observational data, intraindividual modification of dialysate [Na+] from 138 to 142 to 135 mmol/l resulted in concordant changes in skin Na+ (24.3 ± 7.6 vs. 26.3 ± 8.0 vs. 20.8 ± 5.6 a.u, P < 0.05 each), whereas no significant change in muscle Na+ occurred. CONCLUSION: Solely adjustment of dialysate [Na+] had a reproducible impact on tissue Na+ content. 23Na-MRI could be utilized to monitor the effectiveness of dialysate [Na+] modifications in randomized-controlled outcome trials.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kopp C, Kittler L, Linz P, et al. Modification of Dialysate Na+ Concentration but not Ultrafiltration or Dialysis Treatment Time Affects Tissue Na+ Deposition in Patients on Hemodialysis. Kidney Int Rep. 2024. PMID: 38707813. doi:10.1016/j.ekir.2024.02.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。